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ABSTRACT 
 
The aim of this study is to investigate the mechanism involved in cardiomyocyte and 
skeletal muscle cell death in metabolic syndrome. Specific metabolic syndrome conditions 
focused on in this research are iron overload and hyperglycemia. Both in skeletal muscle 
cells and cardiomyocytes, cell death occurred via intrinsic pathway of apoptosis in 
response to these stimuli. Apoptosis in these cells can lead to further problems such as 
sarcopenia and heart failure. We tested the hypothesis that the mechanism responsible for 
apoptosis was through inhibition of autophagy. Under both iron overload and 
hyperglycemia conditions, I noted that autophagosome formation was significantly 
increased. Furthermore, when autophagy was defective, activation of apoptosis was more 
sensitive to the applied stimuli, or defect in autophagy maximized the event under basal 
conditions. Extending out from this, in cardiomyocytes hyperglycemia-induced cell death 
was alleviated by adiponectin, and less autophagosome formation occurred. Thus 
adiponectin, which is considered to be anti-apoptotic adipokine, acted to alleviate 
hyperglycemia-induced apoptosis. Detailed understanding of the mechanisms involved in 
cell death can uncover new potential therapeutic targets for treating complications of 
metabolic syndrome.  
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Chapter One: Introduction 
1.1 Diabetes and associated complications 
1.1.1 Diabetes Prevalence 
Nowadays people are aware that the incidence of diabetes is increasing. Diabetes 
mellitus is a global metabolic disorder characterized by high blood glucose levels, 
insensitivity to insulin, and/or lack of insulin production [1]. Two major types of diabetes are 
Type 1 (T1D) and Type 2 (T2D). T1D occurs due to the destruction of pancreatic beta cells 
caused by malfunctioning of the immune system. As a result, insulin secretion is 
significantly reduced or absent. On the other hand, T2D is commonly developed later in life, 
and beta cells continue to produce insulin but the production is either not enough or 
insufficient to compensate for the body’s insensitivity to insulin. This condition is referred to 
as insulin resistance. In the United States, about 9% of population had diabetes in 1994, 
and this number increased to 14% in 2012. [2]. Diabetes is the major cause of illness and 
death in the United States, and it causes a burden on the health care system [2]. However, 
this is not only restricted to the USA. Increasing prevalence is also observed in Canada, 
according to Diabetes Canada (Table 1.1), and even worldwide (Figure 1.1).  
It is well known that diabetes is a major risk factor for cardiovascular diseases (CVD). 
Recent studies showed that adults with diabetes have up to 4 times greater risk of dying 
from heart disease compared to those without diabetes [3]. Diabetic individuals may 
exhibit cardiac dysfunction in the absence of hypertension or coronary artery disease, a 
condition known as diabetic cardiomyopathy [4]. Diabetic patients or animals have 
hyperglycemia (elevated blood glucose levels), due to impaired insulin activity and glucose 
catabolism. Progression of diabetes can cause numerous complications not only including 
CVD, but also damage to different organs such as the kidneys, eyes, and nerves. 
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Table 1.1: Diabetes statistics in Canada Estimation of prevalence in 2015 and prediction 
for 2025. Copied from Diabetes Canada (http://www.diabetes.ca/how-you-can-
help/advocate/why-federal-leadership-is-essential/diabetes-statistics-in-canada). Copyright 
permission attached on page 60. 
 
 
 
 
Figure 1.1: Estimated diabetes prevalence in 2015 and predicted number in 2040 
worldwide. Source from International Diabetes Federation. 
(http://www.diabetesatlas.org/resources/2015-atlas.html) Copyright permission attached on 
page 61. 
 
 
North America and 
Caribbean
2015 44.3 million
2040 60.5 million
South and  
Central America
2015 29.6 million
2040 48.8 million
Africa
2015 14.2 million
2040 34.2 million
South East  
Asia
2015 78.3 million
2040 140.2 million
Europe
2015 59.8 million
2040 71.1 million
Western Pacific
2015 153.2 million
2040 214.8 million
Middle East and 
North Africa
2015 35.4 million
2040 72.1 million
Estimated number of people with diabetes worldwide 
and per region in 2015 and 2040 (20-79 years) World
2015 415 million
2040 642 million
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1.1.2 Metabolic Syndrome as predictor of cardiovascular disease (CVD) 
There are many risk factors associated with the development of CVD, and some of 
them can be grouped together under the term metabolic syndrome. Dyslipidemia, 
hypertension, hyperglycemia, low HDL cholesterol level are examples that fall into this 
category [5]. Metabolic syndrome can be a predictor of diabetes, and also a predictor of 
CVD. People who have metabolic syndrome have a high occurrence of new-onset 
diabetes. Furthermore, diabetes itself can predict CVD development. The Framingham 
Heart Study showed that people with diabetes had an almost 20% chance of developing 
Coronary Heart Disease (CHD) within ten years of its onset. Metabolic syndrome can be 
treated by modification of lifestyle, such as increased physical activity and change in diet 
[6]; however, this might not be the case for everyone. Therefore, understanding metabolic 
syndrome at the molecular level is also required.  
 
1.1.3 Heart Failure in diabetes 
There are number of events that can be defined as CVD events, such as 
cardiovascular death, myocardial infarction, ischemic stroke, revascularization, and 
acute coronary syndromes [7]. Heart failure (HF), a condition associated with a 
damaged or weakened heart, is caused by these CVDs, which will further be able to 
cause losing  significant number of myocardial cells [8]. Functionally, HF occurs when 
there is not enough pressure in the heart to pump blood effectively through the 
circulation, or the heart muscle cannot relax properly to accommodate blood flow in 
and out of heart [8]. Impaired contraction and relaxation of cardiomyocyte potentially 
result in heart failure, which is closely related with Ca2+ homeostasis in cardiac muscle 
cells. When cardiomyocytes lose function to properly contract and relax, it would hinder 
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blood to be filled in ventricle, which is known as ventricle diastole [9]. And HF is 
resulted to compensate for abnormal cardiac output, such as increased heart rate, 
where the cardiac output is determined by the product of heart rate (HR) and stroke 
volume (SV) [8]. Studies have shown that heart failure is partly, if not all, due to loss of 
cardiomyocytes. Unlike other cells, cardiac muscle cells have limited ability to be self-
renewed once damaged [10]. Recently, there is increasing evidence showing that 
apoptosis is the key modulator in heart failure [11]. As mentioned previously, it was 
known that people with diabetes have higher risk to develop CVD. The exact 
mechanisms T2D causing HF is multifaceted and need to be further investigated [12].  
HF is a very serious disease, and at present there are not many therapeutic options 
available, highlighting the need to prevent HF in advance.   
  
1.2 Apoptosis 
Apoptosis, also known as programmed cell death, is a highly conserved process with 
roles in development, maintenance of homeostasis, and disease. Apoptosis is involved in 
cell turnover in adult tissues as well as in embryonic development. Kerr and colleagues 
first used the terminology in 1972. They discovered that there was a previously 
undescribed process that reverses mitosis. They observed a two-stage process during 
which nuclear and cytoplasmic condensation occurred, followed by breakage into 
fragments. Then these fragments were to taken up by phagosomes [13].  
Apoptosis can be broadly grouped into two pathways depending on the triggering 
signals– intrinsic and extrinsic (Figure 1.2). A third pathway was also discovered which 
involves T-cell mediated cytotoxicity. While the signalling cascades these pathways use 
are different, they merge at the same endpoint, activation of caspase-3 by cleavage [14].  
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As the name indicates, the intrinsic pathway is normally initiated by internal signals, such 
as damaged DNA, chromosome rearrangement, and hypoxic conditions. These signals 
cause damage to the mitochondria. When this occurs, their membrane potential is 
disturbed, a event called mitochondrial outer membrane permeabilization (MOMP), 
through activation of B cell lymphoma (BCL-2) homology 3 (BH3) -only protein [15]. 
Cytochrome c is then released from the mitochondria into cytosol and binds to Apaf-1 
(apoptotic protease activating factor-1) proteins. This binding changes its conformation and 
recruits procaspase-9 to form the apoptosome complex in the presence of ATP. 
Procaspase-9 will cleave itself and further it will cleave procaspase-3 to potentiate 
activation [16].  
On the other hand, extrinsic pathway of apoptosis is activated by signals come 
through death receptors, tumor necrosis factor (TNF) receptor superfamily. Stimulating 
these receptors such as TNF-related apoptosis-inducing ligand (TRAIL) and FAS, will 
recruit Fas-associated death domain (FADD) and caspase-8 and this will further cleave 
procaspase-3, an effector caspase protein [17, 18]. 
However, intrinsic and extrinsic pathways are not mutually exclusive. Even though 
the signal stimulated by binding to death receptors, it can also cross to intrinsic pathway by 
activating Bcl-2 associated X protein (BAX) and Bcl-2 antagonist or killer (BAK) to cause 
MOMP [17].  
Apoptosis in myocyte can potentially result in serious diseases such as HF and 
sarcopenia. HF is characterized by an increased apoptotic rate of cardiomyocytes, a 
change which is known to play an important role in the progression of the disease [19]. 
Apoptosis has emerged as a potential therapeutic target for treating HF, because unlike 
necrosis, apoptosis can be regulated and by intervening earlier step, it can be prevented 
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Figure 1.2: Different modes of activating apoptosis- extrinsic and intrinsic pathways. 
Extrinsic pathway begins with signals that activate through death receptors (TRAIL and 
FAS). FADD and procaspase-8 would be recruited and further activate effector proteins, 
casapse-3 and caspase-7. Intrinsic pathway is activated by intrinsic lethal signals, which 
will activate BH-3-only proteins to activate Bax and Bak and cause MOMP. Disturbance in 
mitochondrial membrane will release cytochrome c to cytosol, which can bind to Apaf1 to 
form apoptosome. Apoptosome will cause self-cleavage of caspase-9 and will activate 
caspase-3 and casapse-7. Source from “A fate worse than death: apoptosis as an 
oncogenic process” [20]. Copyright permission attached on page 62.  
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[11]. Since cardiomyocytes do not proliferate, and even a small reduction in the number of 
cardiomyocytes is detrimental to cardiac function, prevention is very crucial. In terms of 
skeletal muscle cells, sarcopenia can occur possibly due to loss of muscle nuclei through 
apoptosis. This will affect the quality of muscle, which can further change muscle 
metabolism as well [21].  
 
1.3 Autophagy 
Autophagy is the process that eukaryotes have adapted in order to maintain 
homeostasis at the cellular level [22, 23]. This process is involved in the turnover of cellular 
components, especially under the stress. This stress can be defined as changes in nutrient 
availability, oxygen levels, or energy status [24]. Autophagy can be grouped into 3 
categories: microautophagy, macroautophagy, and chaperone-mediated autophagy. 
Microautophagy, studied mainly in yeast, is the process in which lysosomes or vacuoles 
engulf cytosol or organelles by invagination. Chaperone-mediated autophagy occurs only 
in mammalian cells and requires the presence of a specific sequence on the substrate, 
and a heat shock chaperone (HSC70) to carry out the process. Macroautophagy is the 
most well-known pathway, which can be further sub-classified into 2 categories: non-
selective autophagy, a process to adapt to starvation, and selective autophagy, which 
maintains homeostasis of cytosolic proteins and organelles. In macroautophagy (hereafter 
referred to as autophagy), a double membrane autophagosome is formed and fuses with 
lysosomes to be degraded [25].  
There are many proteins involved in autophagy (Figure 1.3), called Atg (autophagy 
related genes) proteins. The induction of autophagy is controlled by a multi-protein 
complex- Atg1/ULK1 (unc-51-like kinase-1), FIP200 (FAK family kinase-interacting protein 
of 200kDa), Atg13, and Atg101. This complex is activated when mammalian target of 
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rapamycin (mTOR) is inactivated [26, 27]. There are two phosphorylation sites that are 
closely related to autophagy, Ser757 and Ser555. The first is known to be phosphorylated 
by mammalian target of rapamycin complex (mTORC), and the latter is phosphorylated by 
AMP-activated protein kinase (AMPK). The process progresses with the formation of a 
phagophore by forming a complex with Beclin1/Atg6 and vascular protein sorting (VPS) 34 
and VPS 15, which will further activate the class III PI3K complex. Then, elongation of the 
phagophore occurs, involving Atg12-Atg5 and Atg8/LC3 (microtubule-associated protein 1 
light chain 3) [28] [29]. Lastly, the autophagosme will fuse with the lysosome to form an 
autophagolysosome or autolysosome, to be further degraded by lysosomal enzymes [30].  
 
Figure 1.3: Autophagy pathway. Overview of the autophagy pathway. Autophagy begins 
with inactivation of mTOR to activate the ULK1 and P13K-III complexes. Induction of 
autophagy is followed by phagophore formation, or also recognized as elongation, and 
subsequently autophagosome, the vacuole, formation. Source from “The role of autophagy 
in neurodegenerative disease” [31]. Copyright permission attached on page 63. 
 
Autophagic flux (Figure 1.4) refers to the whole process from synthesis of the 
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autophagosome to autophagosome degradation by the lysosome. Since an increase in 
autophagosomes can mean either increase in induction of autophagy or decrease in 
degradation, careful observation is needed [29].  
 
 
Figure 1.4: Autophagic Flux. A description of the dynamic process of autophagic flux, 
from formation of autophagosomes to degradation by lysosomes. The diagram features 
inhibitors to block normal autophagic flux. Rapamycin, Temsirolimus, and Torin acts as 
autophagy inducer to inhibit mTOR. 3-Methyladenine and Wortmannin inhibit phagophore 
formation in earlier stage. BafilomycinA1, Chloroquine, E64d, and PepstatinA blocks 
autophgosome binding to lysosome. Source from “Autophagy protects proximal tubular 
cells from injury and apoptosis” [32]. Copyright permission attached on page 64. 
  
 
1.4 Iron metabolism/Iron overload 
1.4.1 Iron Metabolism 
The most common states of iron in biological and physiological settings are the 
ferrous (Fe2+) and ferric (Fe3+) forms. Different forms of iron can be found depending on 
the site in the body. The majority of iron in the body is stored in the ferric form. Iron is first 
taken up by the cells in the ferrous form, primarily by the small intestine, but is quickly 
oxidized to the ferric form by enzymes [33]. Maintenance of internal iron homeostasis is 
important because iron can participate in ROS formation [34]. Iron participates in the redox 
reaction due to its unpaired electrons. Fenton discovered that the oxidation of tartaric acid 
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was catalyzed by the presence of iron and hydrogen peroxide (Fenton, 1894). Later, Haber 
and Weiss demonstrated that in the presence of iron and hydrogen peroxide, the hydroxyl 
radical produced is very reactive, and this will initiate the chain reaction of lipid 
peroxidation [35].  
Fe2+ +H2O2 →Fe3+ +OH
.
+OH− 
Cells maintain their iron balance by two mechanisms. First through ferritin, which is 
known as an iron storage protein. Ferritin deposits excess iron and allows iron to be 
transported. The second means of regulation is through iron regulatory proteins (IRPs). 
Basically, this protein regulates production and degradation of iron responsive elements 
(IREs) that control iron metabolism [34]. 
 
1.4.2 Iron overload and diabetes 
People are aware that a deficiency in the daily iron supply can cause many health 
problems such as anemia, fatigue, and impaired immune function [36]. Iron deficiency is 
reportedly the most common micro-nutritional deficiency in the world [37]. Conversely, 
there are also a rising number of studies showing that excessive iron in the body can 
impair cellular activities. Iron utilization must be tightly regulated, since there is no 
physiological process that mediates excretion of large amounts of iron, except for losing a 
large amount of blood [38]. The disorder characterized by an overabundance of iron is 
called hemochromatosis, and this can be caused by genetic mutation or overdosing on 
iron supplements. Iron overload can result in cardiac toxicity and dysfunction of the 
endocrine system by damaging tissue with an excessive amount of free radical production 
[39]. In particular, previous research has found that the concentration iron stores in the 
body are correlated with the development of T2D [40]. This raises the possibility that 
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excessive iron can lead to diabetes [41]. This is supported by studies showing that iron 
plays a role in the regulation of glucose metabolism and insulin resistance.  
 
1.4.3 Effect of iron overload on cellular mechanisms 
1.4.3.1 Iron and oxidative stress 
At the cellular level, iron plays an important role in the formation and destruction of 
reactive oxygen species (ROS) through a process known as the Fenton reaction [42]. 
When there is massive ROS production in the cells, cells experience oxidative stress. 
Oxidative stress is a condition in which the balance of ROS and antioxidant defense is 
unstable [43]. Progression of oxidative stress will further cause cell death [44]. 
Mitochondria are organelles that are very closely related to iron metabolism. The electron 
transport chain, one of the processes in which iron participates, occurs in mitochondria. 
Also, there are mitochondrial proteins that contain iron. MitoNEET, which is named based 
on the amino acid sequence Asn-Glu-Glu-Thr (NEET), is one of the proteins that resides in 
the outer mitochondrial membrane and regulates oxidative capacity [45].  
 
1.4.3.2 Iron and autophagy 
As mentioned previously, autophagy is a well-known for survival mechanism under 
conditions of disturbance in cellular homeostasis, during which catabolic processes are 
initiated to conserve energy and nutrients [46, 47].  
As more studies on autophagy are done, researchers have found more specific 
autophagic pathways, as known as selective autophagy. In these cases, they name the 
selective autophagy based on the substrate it degrades, i.e., mitophagy for mitochondria 
and ferritinophagy for ferritin. In terms of iron, there are no direct studies showing effect of 
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iron overload on autophagy. When there is an increase in iron, ferritin is stabilized and 
NCOA4, which is a cargo protein for ferritinophagy, will be degraded, which is observed as 
a decrease in NCOA4. Such an observation would indicate a decrease in ferrtinophagy 
[48]. The study of autophagy with iron metabolism is a relatively new area, which has 
potential to be a great therapeutic target to treat many diseases. 
 
1.4.3.3 Iron and apoptosis 
Apoptosis, also known as programmed cell death, is a conserved process which aids 
in development, homeostasis, and disease. Similar to autophagy, apoptosis can be 
considered as either a beneficial or detrimental process to cells. Previous studies have 
shown iron overload can cause apoptosis in different cell types such as cardiomyocytes 
[49], hepatocytes [50], and osteocytes [49]. However, the mechanism(s) involved in iron-
overload cell death are not fully understood. 
There is special area that study iron induced cell death, called ferroptosis. This is 
found to be distinct from apoptosis, where features of event are slightly different. In 
apoptosis, the main biochemical feature is the activation of caspases as well as PS 
exposure. However, in ferroptosis, neither events are predominant, rather glutathione 
(GSH) depletion and increasing Nicotinamide adenine dinucleotide phosphate (NAPDH) 
oxidation occur [51]. Ferroptosis is normally resulted from lipid peroxide accumulation from 
iron-dependent pathway [52]. Discovering role of iron in apoptosis and ferroptosis will be 
very helpful to understand cell death in iron-overload associated diseases. 
 
1.4.4 The role of oxidative stress in appoptosis 
Both oxidative stress and apoptosis are essential for normal function of 
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cells and for survival. However, over-activation of these processes can cause 
diseases. Recently, studies illustrated that oxidative stress plays crucial role in 
apoptosis. For example, experiments showed that excess oxidative stress kills 
cells by apoptosis [53, 54] and antioxidants can delay, or even block apoptosis 
[55]. Mitochondria are the place where apoptosis and oxidative stress share in 
common. They are the sites where majority of oxygen radicals generated, which 
can cause oxidative stress. Also, cytochrome C release from mitochondria 
mediates apoptosis.  
 
1.5 Adiponectin 
1.5.1 Adiponectin structure 
Adipokines are cytokines that are produced from adipose tissue [56]. There are 
several examples of adipokines including leptin, tumor necrosis factor-a (TNF-a), Visfatin, 
lipocalin-2, and acylation-stimulating protein (ASP) [57, 58]. Lipocalin-2, for example, is a 
pro-inflammatory hormone that is positively correlated with various metabolic parameters 
such as body mass index (BMI) and body fat percentage [58]. Adiponectin (also known as 
GBP-28, apM1, adipoQ, and Acrp30) is another example of an adipokine. Adiponectin can 
be found in either a 17kDa globular form (gAd) or the full-length form (fAd), and fAd can 
further be divided into 3 categories according to its polymerization and molecular weight: 
low (LMW), middle (MMW), and high molecular weight (HMW). These forms are a 90kDa 
trimer, a 180kDa hexamer, and a higher order oligomer, respectively [59]. Among these 
different sizes of adiponectin, it is the HMW one that is thought to have the most biological 
activity in the body [60].  
  
1.5.2 Associations between adiponectin and heart failure 
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Unlike Lipocalin-2, described above, there is a growing body of evidence that 
suggests a negative relationship between adiponectin levels and HF. One study showed 
that in adiponectin knockout (KO) mice, cardiac hypertrophy and mortality rates increased 
[61]. Another study demonstrated that acute myocardial infarction (MI) was observed to 
correlate with a decline in adiponectin levels [62]. In one study, it was shown that 
hypoadiponectinemia, where there is a low plasma adiponectin level, was closely related 
to diseases related to obesity such T2D, CHD, and hypertension [63]. 
 
1.5.3 Cardioprotective effects of adiponectin 
There is evidence that adiponectin has many physiological functions such as insulin-
sensitization, anti-diabetic, anti-inflammatory, and anti-atherosclerotic effects [58, 64]. Of 
note, many studies have shown that adiponectin has a cardioprotective function in the 
heart under pathological conditions [63]. Adiponectin knockout mice showed a greater 
extent of stress response in cardiac tissue compared to wild-type mice. For instance, after 
myocardial ischemia-reperfusion injury, adiponectin knockout mice showed a larger infarct 
area, enhanced concentric cardiac hypertrophy, and increased mortality [63]. However, the 
function was rescued when exogenous adiponectin was supplied [60]. One of the ways 
that adiponectin is believed to protect against cardiomyopathy is through enhancing the 
AMP-activated protein kinase (AMPK)- dependent signalling pathway. There is evidence 
proves  that adiponectin helps from apoptosis through AMPK pathway from high glucose 
toxicity in tubular cells [65] and in endothelia cells [66]. Therefore, adiponectin is thought to 
have an anti-apoptotic function through activation of the AMPK signaling pathway to inhibit 
apoptosis in cardiac cells [63]. 
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1.6 Effect of hyperglycemia on cellular mechanisms 
1.6.1 Hyperglycemia and autophagy 
In animal models, diabetic rats have been shown to have suppressed autophagy [67]. 
When autophagy was up-regulated using a pharmacological inducer of autophagy, 
metformin, a cardiac protective role was demonstrated in the diabetic heart [68]. Further, 
induction of autophagy prevented hyperglycemia-induced cardiomyocyte cell death in 
H9c2 cells[69]. In other model, glucose infused- hyperglycemia inhibited autophagy in rat 
skeletal muscle [70].  
1.6.2 Hyperglycemia and apoptosis 
In cardiomyocytes, hyperglycemia induces apoptosis [71]. HF is characterized by an 
increased apoptotic rate of cardiomyocytes, which is known to play an important role in the 
progression of the disease. Apoptosis has emerged as a potential therapeutic target for 
treating heart failure, since cardiomyocytes do not proliferate and even a small reduction in 
the number of cardiomyocytes is detrimental to cardiac function [19]. Hyperglycemia 
increases cardiomyocyte apoptosis, which leads to diabetic cardiomyopathy and HF [72]. 
In the study by Cai and his colleague, they showed that STZ-induced diabetic mice had 
more apoptosis occurrence in the heart compared to control or insulin-supplemented 
diabetic mice. And this was supplemented with in vitro experiment, which showed that 
increased caspase-3 activation upon high levels of glucose treatment.  
 
1.7 Hypothesis and research aims 
Studies had proven that iron-overload and hyperglycemia are observed in metabolic 
syndrome patients and animal models of diabetes, and furthermore, that these conditions 
can induce apoptosis. However, the mechanism(s) behind how these stimuli cause 
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apoptosis are not yet fully understood. Thus, the aim of my study is to investigate the 
mechanism(s) through which conditions commonly observed in metabolic syndrome 
induce cell death in relevant target cell types.  
 
For my first project, the hypothesis was that iron overload induces intrinsic apoptosis, 
and that this was mediated by reduced autophagic flux and/or increased oxidative stress, 
and possibly by crosstalk between them. The relationship between autophagy and iron-
overload induced apoptosis is not well elucidated. To investigate their interactions, I used 
in vitro models of both wild type and autophagy-deficient L6 myoblast cells treated with 
iron for 24 hours, and tested ROS production, autophagic flux, and apoptosis.  
For my second project, I hypothesized that adiponectin would have a beneficial effect 
on apoptosis by activating autophagy under hyperglycemic conditions in cardiomyocytes. 
In hyperglycemia, reduced levels of autophagy and increased levels of apoptosis are 
expected. However, when treated with adiponectin, the autophagy level would increase to 
prevent cells from undergoing apoptosis. In this project, I used H9c2 cardiomyocyte cells 
treated with adiponectin in both normal glucose and high glucose conditions and examined 
autophagy and apoptosis.   
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Chapter 2 Iron-overload induces cell death via inhibition of autophagic flux and/or 
by promotion of oxidative stress in L6 skeletal muscle cells 
2.1 Preface 
Iron overload can result in cardiac toxicity and dysfunction of the endocrine system 
by damaging tissue through an excessive amount of free radical production. When there is 
massive ROS production in cells they experience oxidative stress, and this will cause cell 
death. Muscle is one of the largest reservoirs for iron in the body, along with liver, spleen, 
and bone marrow. Though the concentration of iron in muscle is lower than other organs, 
muscle mass is much larger, thus the total amount of iron is very similar to other tissue 
types. Based on three different apoptosis assays, caspase-3 western blot and 
immunofluorescence, and a cytochrome C/mitotracker co-localization assay, I concluded 
that iron overload conditions increase apoptosis in L6 skeletal muscle cells. Also, iron 
overload caused accumulation of autophagosomes, as demonstrated by cytoID 
immunofluorescence. In autophagy deficient cells (Atg5K130R), there was a significant 
increase in apoptotic activity. Lastly, in order to link autophagy, oxidative stress, and 
apoptosis, I measured ROS production with CellROX reagents, and showed an elevation 
in ROS production with iron treatment, and reduction upon co-treatment with the 
antioxidant reagent, MnTBAP.  
In conclusion, my study confirmed that iron overload induced the intrinsic pathway of 
apoptosis. Additionally, iron overload also provoked autophagosome formation. Based on 
results thus far, inhibition of autophagy appears to exacerbate apoptosis.   
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2.2 Introduction 
People are aware that a deficit in the daily iron supply can cause many health 
problems such as anemia, fatigue, and impaired immune function [36]. Iron deficiency is 
reportedly the most common micro-nutritional deficiency in the world [37]. However, an 
increasing number of studies have now shown that excessive iron in the body can impair 
cellular activities. Iron overload can result in cardiac toxicity and dysfunction of the 
endocrine system by damaging tissue through an excessive amount of free radical 
production [39]. In particular, previous research has found that the concentration of iron 
stores in the body are correlated with development of T2D [40] raising the possibility that 
iron overload can lead to diabetes [41]. Muscle is one of the largest reservoirs for iron in 
the body along with the liver, spleen, and bone marrow. Even though the concentration of 
iron in the muscle is lower than other organs, muscle mass is much larger, thus the total 
amount of iron contained in the tissue is very similar to others [73].  
At the cellular level, iron plays an important role in the formation and destruction of 
reactive oxygen species (ROS), through a process known as the Fenton reaction [42]. 
When there is massive ROS production in cells they experience oxidative stress, and this 
will cause cell death [44]. Therefore, the level of ROS has to be tightly controlled and 
autophagy plays a role in this process.  
Autophagy is a well-known survival mechanism utilized by cells in response to 
disturbance in their homeostasis, during which catabolic processes are initiated to 
conserve energy and nutrients [46, 47]. It can be divided into two main steps- formation of 
autophagosomes by engulfing organelles, and breakdown of these autophagosomes by 
lysosomes [47]. An increasing number of discoveries about the autophagic process have 
been published, generating controversy over whether it is beneficial or detrimental to cells. 
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Arguments can be different depending on their context; however, it has been observed that 
autophagy can be a defense mechanism against oxidative stress [74].   
Apoptosis, also known as programmed cell death, is a conserved process, which 
aids in development, homeostasis, and disease. It is a natural process that is involved in 
cell turnover in adult tissues, as well as during embryonic development. Similar to 
autophagy, apoptosis can be considered to be either a beneficial or detrimental process to 
cells depending on the context. There have been studies showing that inhibition of 
autophagy elevates apoptosis in various cell types [75-77] 
The relationship between autophagy and iron-overload induced apoptosis is not well 
elucidated. Based on previous research, I hypothesized that iron overload induces intrinsic 
apoptosis, and this is mediated by reduced autophagic flux and/or increased oxidative 
stress, and potentially crosstalk between them. To investigate interactions between these 
pathways, I used both wild type and autophagy deficient L6 myoblast cells treated with iron 
for 24 hours and tested ROS production, autophagic flux, and apoptosis activity.   
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2.3 Materials and Methods 
2.3.1 L6 myoblast cell culture and treatment 
L6 skeletal muscle cells were maintained in Alpha modification of Eagle’s Medium 
(AMEM) from Wisent Bioproduct supplemented with 10% fetal bovine serum (FBS) from 
Gibco and 1% Antibiotic-antimycotic (vol/vol) from Gibco. Cells were maintained at 37 °C 
with 5% CO2 in a 75cm2 flask. During cell growth, when cells reached 80% confluence, 
they were trypsinized and seeded for experiments. Prior to treatments, cells were starved 
for 2 hours in FBS-free AMEM. According to treatment conditions specified in the results, 
cells were treated with 0.5% FBS AMEM and FeCl3 250uM, Chloroquine 30uM, and 
MnTBAP 10uM. 
2.3.2 Generation of L6-ATG5K130R mutant cell line  
Autophagy-deficient L6 cell stably overexpressing dominant negative Atg5 with 
lysine(K) mutated to arginine(R) at position 130 was generated. The virus produced from 
ecotropic packaging cell line, Ecopack2-293, was infected to L6 myoblast cells in sterile 
condition. Using retroviral expression vector, pQCXIP, containing puromycin resistance, 
virus was produced. Cells were incubated with virus for 24hours in the incubator. Cells 
were maintained in growth media containing puromycin (2ug/mL; Sigma-Aldrich). 
2.3.3 Western blot Analysis 
After treatment, L6 cells were washed in phosphate buffered saline (PBS). 120uL of 
lysis buffer [0.5 M tris-hydrochloride (Tris-HCL) pH 6.8, 2% (vol/vol) sodium dodecyl 
sulphate (SDS), 15% (vol/vol) glycerol, 10% (vol/vol) 2-mercaptoethanol, and protease 
inhibitor cocktail] was added to each well and cells were scraped off. The lysates were 
then incubated at 95°C for 10 minutes. Approximately 35ug of protein was loaded to each 
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well. Samples were analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
and transferred to a polyvinylidine fluoride (PVDF) membrane. The membranes were 
blocked in 3% BSA for 1 hour and were left in primary antibodies overnight. Western blot 
analysis was performed using specific primary antibodies to Caspase-3, LC3B, and 
GAPDH (1:1000, Cell Signaling). HRP-linked secondary anti-rabbit (1:5000, Cell Signaling, 
MA) was used as secondary antibody and proteins were detected by enhanced 
chemiluminescence reagent (BioRad). The membranes for caspase-3 were stripped each 
time and re-probed with antibodies against GAPDH (1:1000, Cell Signaling, MA) as 
loading controls. Band intensity was quantified using ImageJ software. 
 
2.3.4 Detection of mitochondrial cytochrome c release 
Mitotracker Red CMXRos (ThermoFisher Scientific) at 250nM was loaded into wells 
for 30 minutes at 37°C. Cells were fixed in 4% Paraformaldehyde for 20 minutes at room 
temperature and permeabilized using 0.1% Triton X-100. Overnight incubation with 
Cytochrome C (clone 6H2.B4, BD PharmingenTM, 1:400) primary antibody was followed by 
1 hour incubation with Goat anti-Mouse IgG, Alexa Fluor 488 (ThermoFisher, 1:800). 
Coverslips were mounted on microscope glass slides using DAPI mounting medium 
(Vector Laboratories Inc., USA) and analyzed using fluorescence microscopy. The images 
were taken using 40x objective of LSM 700 confocal microscope with DAPI, FITC, and 
TRITC channels for nucleus, cytochrome c, and mitotracker, respectively. Experiments 
were done 3 separate experiments and each experiment consisted of 3 fields of view that 
were selected randomly. Pearson Coefficients were calculated using the JACoP plug-in in 
ImageJ software to calculate co-localization.  
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2.3.5 CYTO-ID® Assay (Product from Enzo) 
L6 cells were seeded onto 18mm coverslips and treated according to their respective 
treatment plan. Cells were washed twice with 1x Assay Buffer, then 2uL of CYTO-ID® 
Green Detection Reagent, and 1 uL of Hoechst 33342 Nuclear Stain was mixed into 1mL 
of 1x Assay Buffer. 100uL of this mixture was added on top of the coverslip. Samples were 
incubated for 30 minutes at 37°C in the dark. Then cells were washed with 100uL of 1X 
Assay Buffer and fixed with formalin for 20 minutes. Cells were washed with 1X Assay 
Buffer three times and mounted on the glass slide with Prolong mounting medium 
(Prolong). Using the FITC filter for autophagic signal and DAPI filter for nuclear signal by 
confocal microscope (Zeiss LSM700), images were taken at 40x objectives. 3 different 
fields of view were selected randomly per experiments for 3 separate experiments and 
analyzed using Image J software.  
 
2.3.6 CellROX Green Assay 
5uM of CellROX Green Oxidative Stress Reagent (Life Technologies) was added to 
each well and incubated for 30 minutes at 37°C in the dark. The cells were fixed with 4% 
PFA for 15 minutes, and mounted on a glass slide with DAPI mounting medium (Vector 
Laboratories Inc., USA). Using FITC and DAPI filters in confocal microscopy, images were 
taken using the 20x objective (Zeiss LSM700). 
 
2.3.7 CellROX Deep Red Assay 
5uM of CellROX Deep Red Oxidative Stress Reagent (Life Technologies) was added 
to each well and incubated for 30 minutes at 37°C in the dark. The cells were fixed with 4% 
PFA for 15 minutes, and mounted on a glass slide with DAPI mounting medium (Vector 
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Laboratories Inc., USA). Using TRITC and DAPI filters in confocal microscopy, images 
were taken using the 20x objective (Zeiss LSM700). 
 
2.3.8 Statistical analysis 
All data are presented as mean ± SEM. Statistical analysis was performed using 
Student’s t-test when comparing 2 groups. To compare experiment with more than 2 
groups, one way ANOVA followed by Dunnett’s post-test was performed. The differences 
among groups were considered statistically significant when p<0.05 and are indicated by 
symbols as described in figure legends.  
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2.4 Results 
 
2.4.1 Iron overload causing apoptosis in L6 skeletal muscle cells. 
To confirm iron overload causes apoptosis in L6 skeletal muscle cells, cells were first 
treated with 250uM of FeCl3 for 24 hours. Two different assays, western blot and 
immunofluorescence, were done to see treatment induced activation of caspase-3, which 
is a known effector protein of apoptosis. A significant increase in cleaved caspase-3 was 
observed with 24 hours of iron treatment by western blot (Figure 2.1 A, B). Additionally, 
CelleventTM Caspase3/7 Green Detection Reagent, a fluorescent indicator activated by 
active caspase-3, demonstrated localization of caspase-3 within nucleus (Figure 2.1 C). 
This was quantified as co-localization of FITC to DAPI, and there was significant increase 
of co-localization upon iron treatment (Figure 2.1 D).  
To further investigate the activation of intrinsic apoptosis, a cytochrome 
C/mitotrackerTM co-localization assay was performed. This assay allows us to determine 
whether cytochrome C has been released out of mitochondria to the cytoplasm to further 
activate the cascade reaction of apoptosis. Merged images of the two different conditions 
showed that in controls, cytochrome C primarily resided inside mitochondria (represented 
by yellow punctae). There was a significant decrease in cytochrome C and mitotracker co-
localization upon iron treatment. Images were then quantified and represented as a 
Pearson’s coefficient ratio (Figure 2.1 E, F).  
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Figure 2.1 Iron overload inducing apoptosis in L6 cells. L6 cells were treated with 
FeCl3 (250uM) for 24 hours. Western blots showing total and cleaved forms of caspase-3 
and the loading protein, GAPDH (A) and quantification for cleaved caspase-3 form over 
GAPDH (B). Representative images to show increased activation of caspase-3/7 (green) 
within nucleus (C) and quantification of its co-localization using Pearson’s coefficient (D). 
Representative images to show increase in activation of intrinsic apoptosis was visualized 
using cytochrome C (green) and mitotracker (red) co-localization (E) and quantification 
using Pearson’s coefficient (F). * indicates significant difference from control p<0.05. *** 
indicates significant difference from control p<0.001 (n=3). 
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2.4.2 Iron overload inducing autophagosome formation. 
To establish the relationship between autophagy and apoptosis upon iron overload 
conditions, I focused on autophagic flux. To visualize autophagosome formation, cytoID 
reagent was used. This novel reagent allows visualization of the autophagosome by 
cationic amphiphilic tracer (CAT) dye that goes into cells in a similar way as 
phospholipidosis, and labels autophagic vacuoles. Result showed that upon treatment with 
iron, there was a significant increase in total green fluorescence (Figure 2.2 A, B). 
Western blot supported IF images, in which the lipidated form of LC3, LC3II, a marker for 
autophagosomes, increased upon iron treatment (Figure 2.2 C, D).  
 
2.4.3 Autophagy deficiency did not accelerate apoptosis 
Chloroquine, which is the inhibitor of autophagic degradation, was co-treated with 
iron to see whether blocking autophagy can further activate apoptosis. Consistent with 
previous data, iron overload increased cleaved caspase-3 activation. However, when 
chloroquine was treated along with iron, there was a decrease in not only cleaved 
caspase-3, but also total caspase-3 levels (Figure 2.3 A, B).  
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Figure 2.2 Iron overload inducing autophagosome accumulation. L6 cells were 
treated with FeCl3 (250uM) for 24 hours. Representative images to show increase in 
autophagosome formation by CytoID (A) and its quantification (B). * indicates significant 
difference from control p<0.05 (n=3). Increase in autophagosome formation also supported 
by western blot of LC3 (C) and its quantification (n=1) (D). 
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Figure 2.3 Reduction of iron-overload induced apoptosis with autophagy inhibitor.  
L6 cells were treated with FeCl3 (250uM) with or without chloroquine (CQ, 30uM) for 24 
hours. Western blots showing total and cleaved forms of caspase-3 and the loading protein 
GAPDH (A) and quantification for cleaved casapse-3 over GAPDH (B). no statistical 
difference in one way ANOVA followed by Dunnett’s post-test, but using Student t-test to 
compare only between control and Fe3+, * indicates significant difference from control 
p<0.05 (n=3). 
  
 
To further investigate the linkage between autophagy and apoptosis, more 
experiments comparing autophagy-deficient Atg5K130R and control empty vector (EV) cells 
were performed. Atg5K130R are dominant negative cell lines in which autophagy is down-
regulated, not completely knocked out. To confirm that the cell lines are properly 
functioning, cytoID immunofluorescence (Figure 2.4 A) and LC3 western blots (Figure 2.4 
B) were performed. There was no autophagosome formation observed when cells were 
starved. However, when treated with iron, autophagosomes accumulated even in the 
Atg5K130R cell line. This demonstrated that autophagy was not completely knocked out, but 
it was significantly down regulated in this line. 
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After confirming Atg5K130R cell lines are functioning appropriately, I performed the 
same set of apoptosis analysis performed previously, including Caspase-3 western blot, 
and immunofluorescence using CelleventTM Caspase3/7 Green Detection Reagent. In both 
EV- and Atg5K130R cells the level of cleaved Caspase-3 increased with iron treatment. Even 
though the absolute difference seemed to be greater in EV- cells, the fold increase 
between control and iron-treated groups was greater in Atg5K130R cells (Figure 2.4 C, D). 
Comparing control and iron-overloaded Atg5K130R cells, there was a significant increase in 
activation of Casapse-3/7, as indicated by green signals localized in nucleus. A similar 
trend was observed with EV- cells; however, the green signal was much weaker with iron 
treatment as compared to Atg5K130R cells (Figure 2.4 E). 
 
2.4.4 Iron overload induces ROS production in L6 skeletal muscle cells 
Lastly, to investigate another mechanism through which iron overload may induce 
cell death, I measured reactive oxygen species (ROS) production in L6 cells with both 
CellROX green and red reagents (Figure 2.5). The images from confocal microscopy 
showed that intracellular ROS production was increased upon iron treatment in both 
experiments, and this was then reduced by co-treatment with 10uM MnTBAP, a ROS 
scavenger.  
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Figure 2.4 Reduced apoptosis activity in autophagy deficient cell line. Confirmed that 
Atg5K130R and EV- L6 cells were well transfected by comparing starved condition using 
cyto ID (A) and western blot of LC3B and GAPDH (B). Atg5K130R and EV- L6 cells were 
treated with FeCl3 (250uM) for 24 hours. Western blot of caspase-3 and loading control 
protein GAPDH (C) was performed and quantification of iron condition normalized to 
control, which represented by dotted line, for cleaved caspase-3 over GAPDH is provided 
(D). Representative images to show increased activation of caspase-3/7 (E).* indicates 
significant difference from control p<0.05 (n=3). 
 
 
 
Figure 2.5 Iron overload inducing ROS production in L6 cells. L6 cells were treated 
with FeCl3 (250uM) with or without MnTBAP (10uM) for 24 hours. Representative images 
to show increased ROS production with iron treatment and alleviation with ROS scavenger, 
MnTBAP, using CellROX Green assay and CellROX Deep Red assay. 
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2.5 Discussion and Future Plan 
Excessive iron in the body could result in impairment of cellular activities. In clinical 
studies, excessive iron in tissues was closely linked to the development of T2D [78]. 
Although the concentration was lower than other organs such as liver, spleen, and bone 
marrow, skeletal muscle was one of the largest reservoirs of iron if the total amount was 
compared due to the large mass of muscle in the body [73]. In the present study, I found 
that long-term iron treatment resulted in apoptosis, autophagosome accumulation, and 
excessive oxidative stress in L6 skeletal muscle cells.  
Upon iron treatment, cleaved Caspase-3 levels were significantly increased, and 
cytochrome C was released into the cytosol from damaged mitochondria. Consistent with 
previous studies, my results showed that iron overload up-regulated apoptosis in L6 cells. 
Previous studies have shown that iron overload causes cell death in different types of cells, 
such as cardiomyocytes [49], hepatocytes [79], and bone marrow cells [80].  Apoptosis, 
also known as programmed cell death, is when a cell commits suicide in response to 
stimuli [81]. Caspase-3 is an effector protein that carries out apoptosis [82]. This protein 
was widely used as a marker to check for activation of apoptosis. Additionally, a 
Cytochrome-c and mitochondria co-localization assay allowed us to visualize whether 
damaged mitochondria resulted in release of cytochrome-c to the cytosol where it would 
trigger the intrinsic pathway of apoptosis [16].  
Upon treatment with iron for 24 hours there was a significant increase in the number 
of autophagosomes detected. Autophagy is a survival mechanism which eukaryotes have 
adapted to resist against various stresses such as limitations in nutrient availability or 
oxygen levels [24]. There are multiple stages of autophagy progression, but in my study, I 
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focused on the stage involving autophagosomes. Autophagosome accumulation could be 
interpreted in two ways, either as increase in induction of autophagy or decrease in 
autophagosome degradation [29]. CytoID is a novel reagent that was used to visualize the 
presence of autophagosomes, together with the expression level of LC3II. To better 
understand autophagic flux, these studies would need to be complemented with further 
experiments examining the activation of autophagy or blocked degradation of 
autophagosomes.  
There have been many studies that have speculated a relationship between 
autophagy and apoptosis, yet still no definite connection has been made. This is probably 
due to the multiple proteins involved that could behave differently in different environments 
and different cell types [47]. In order to characterize the interrelationship between 
autophagy and apoptosis in skeletal muscle cells, I performed experiments in a setting 
where autophagy was blocked either chemically or genetically. Chloroquine is one of the 
commonly used blockers of autophagy, along with bafilomycin A1, which could inhibit 
degradation of autophagosomes [83]. For genetic inhibition, a special mutant L6 cell line 
was used. The Atg5K130R cell line expresses a dominant negative Atg5 in which a point 
mutation replaces arginine (R) to Lysine (K) at position 130 [84]. In the beginning, I 
hypothesized that blocking autophagy would increase apoptotic activity. Interestingly, co-
treatment with iron and chloroquine showed lower activation of apoptosis compared to 
iron-only treatment. However, taking the results for total caspase-3 into consideration, it 
was determined that not only the cleaved form but also total form of caspase-3 decreased. 
Previous research has found that chloroquine could inhibit cell growth, and could also 
induce cell death through the inhibition of autophagy, however the mechanism is unknown 
[85] and could possibly involve a caspase-3 independent pathway. This suggests that 
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chloroquine has a role in blocking autophagy, however, it causes cell death through a 
different pathway. In autophagy-deficient cells, there was greater increase of casaspe-3 
activation with iron treatment compared to control empty vector cells. This suggested that 
when autophagy was impaired, more apoptosis could be triggered.  
My data so far suggests that there is a significant increase in ROS production with 
iron treatment in both the nucleus and cytoplasm; however, oxidative stress induced by 
iron overload was abolished by the antioxidant reagent, MnTBAP. It is believed that in 
many diseases related to iron overload the organs are damaged by excessive ROS 
production [42]. This can damage mitochondria, which could further initiate apoptotic cell 
death in many cell types [14]. My findings are consistent with other studies that ROS 
production is increased by iron treatment.  
In summary, skeletal muscle cells were very responsive to iron overload-induced 
apoptosis. There was a significant induction of autophagosome formation and ROS 
production. Future studies will focus on looking at autophagosome degradation in 
autophagic flux, as well as investigating crosstalk between autophagy and oxidative stress 
in iron overload-induced apoptosis. This, in the future, can provide a new direction of drug 
discovery for iron overload-associated diseases  
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Chapter 3: Adiponectin alleviates hyperglycemia-induced cell death via improving 
the autophagic pathway in cardiomyocytes 
3.1 Preface 
It is known that diabetes is characterized by elevated blood glucose, a condition 
called hyperglycemia. Hyperglycemia increases cardiomyocyte apoptosis, which leads to 
HF. Previous work has demonstrated that adiponectin has a protective effect against 
apoptosis. Therefore, based on previous studies, my aim is to determine through which 
pathway adiponectin mediates its beneficial effect on apoptosis. The mechanism I propose 
is through autophagy, specifically improving autophagic flux. I have found that adiponectin 
reduces high glucose-induced cell-death. I examined this by using a trypan blue exclusion 
assay, an annexin V/PI staining assay, a TUNEL assay, and a Caspase-3 activity assay. 
Also, using a mitotracker and cytochrome C co-localization assay, I verified that 
hyperglycemia-induced cell death is mediated by the intrinsic pathway of apoptosis. In 
terms of autophagy, high glucose treatment induced autophagosome formation, and again, 
adiponectin alleviated this condition. When autophagy was impaired, apoptosis increased 
even under normal conditions, but adiponectin treatment was able to reduce caspase-3 
activation. This suggested that adiponectin may function to reduce apoptosis through a 
different pathway when autophagy is not fully functioning.  
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3.2 Introduction 
Diabetes mellitus is a metabolic disorder with global prevalence characterized by 
high blood glucose levels, insulin insensitivity, and/or an inability to produce insulin [1]. It is 
well known that diabetes is the major risk factor for CVD. Diabetic patients or animals have 
an elevated glucose level in the blood, a condition called hyperglycemia. HF is 
characterized by an increased apoptotic rate of cardiomyocytes, which is known to play 
substantial role in the progression of the disease [19]. Apoptosis has emerged as a 
potential therapeutic target for treating HF since cardiomyocytes do no proliferate, and 
even a small reduction in the number of cardiomyocytes is detrimental to cardiac function. 
It has been discovered that hyperglycemia increases cardiomyocyte apoptosis, which then 
leads to diabetic cardiomyopathy and HF [72].  
It is now known that a circulating hormone secreted from adipocytes, adiponectin, 
has a protective effect in many cardiac remodeling events such as hypertrophy, fibrosis, 
metabolism, and cell death [58]. One of the ways that adiponectin exerts its cardio-
protective function is through the AMP-activated protein kinase (AMPK)- dependent 
signaling pathway [63]. AMPK is involved in many cellular regulatory roles, one of which is 
to act as an inducer of autophagy. This suggest the possibility that adiponectin modulates 
autophagy. The mechanism underlying adiponectin’s role in regulating autophagy and 
apoptosis needs to be better understood. 
Based on previous research, I hypothesized that adiponectin will have a beneficial 
effect on reducing apoptosis by activating autophagy under hyperglycemic conditions in 
cardiomyocytes.   
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3.3 Materials and Methods 
3.3.1 Cell culture and treatments 
H9c2 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) from Gibco and 1% 
penicillin/streptomycin (v/v). When cell populations reached 80% confluence in 75cm2 
flasks at 37 °C with 5% CO2 they were either passaged or seeded for experiments. 
Cultures were exposed to D-glucose at a final concentration of 25mmol/L for in vitro 
treatment with high levels of glucose (HG), and 5.5mmol/L D-glucose as control (NG). To 
exclude a hyperosmolar effect, we added of 19.5mmol/L mannitol in control cultures. Cells 
were treated with fAd (5.0ug/mL) for various time points as indicated in figure legends. 
 
3.3.2 Production of fAd 
Post-translationally modified fAd was produced in a mammalian expression system 
(Palanivel, 2007).  
 
3.3.3 Trypan blue exclusion Assay  
Cells were seeded in 6-well plates and incubated in NG or HG with or without fAd 
(5.0ug/mL) for 72 hours. Cells were washed with PBS then trypsinized. 10% FBS DMEM 
was added to neutralize trypsin. Cells were then suspended and treated with 0.1mL of 0.4% 
Trypan Blue Stain for 5 minutes. Using a hemocytometer, cells were counted under light 
microscope. Percentage of trypan blue positive cells over total cell population for each 
sample was calculated. 
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3.3.4 Annexin V binding assay 
Phosphotidylserine (PS) exposure in apoptotic cells was measured using Annexin V-
FITC detection kit (BD Pharmagen, Canada) according to the manufacturer’s protocol. 
Cells were seeded in 12-well plates with coverslips and incubated in NG or HG, with or 
without fAd (5.0ug/mL) for 24 hours. Cells were washed with PBS and binding buffer 
(10mM HEPES pH 7.4, 140mM NaCl, 2.5mM CaCl2), followed by a 20 minute incubation 
with solution containing annexin V-FITC (1:20 dilution) and 1ug/mL propidium iodide, 
diluted in binding buffer solution.  
 
3.3.5 TUNEL assay 
Free 3’-OH DNA termini generated during apoptosis were detected by TUNEL 
staining (Terminal dexoynucleotidyl transferase- mediated dUTP nick end-labeling), with 
dUTP tagged with fluorescence (FITC). The assay was performed using the In Situ Cell 
death Detection Kit, Fluorescein (Roche Applied Science, Canada) according to the 
manufacturer’s protocol. Cells were seeded in 12-well plates with coverslips and incubated 
in NG or HG, with or without fAd (5.0ug/mL). Cells were fixed in 4% Paraformaldehyde for 
1 hour at room temperature and permeabilized using 0.1% Triton X-10 in 0.1% sodium 
citrate. Then cells were incubated in the TUNEL reaction mixture for 1 hour at 37°C. 
Coverslips were mounted on microscope glass slides with DAPI mounting medium (Vector 
Laboratories Inc., USA) and analyzed using fluorescence microscopy. 
 
3.3.6 Casapse-3 activity 
The Caspase-3/CPP32 Colorimetric assay (MBL International Corp., MA, USA) was 
used to measure the activity of caspase-3 according to the manufacturer’s protocol. Cells 
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were grown in a 6 well plate. After incubation in NG or HG, with or without fAd (5.0ug/mL), 
floating cells were collected by centrifugation at 12,000 rpm for 1 min, at room temperature. 
The floating cell pellet combined with adherent cells were lysed in 50uL of chilled lysis 
buffer on ice for 10 min. Supernatant was transferred to a microtube, and incubated with 
DEVD-pNA substrate at 37°C for 1.5hrs. After the incubation time, 100ul of each sample 
was transferred to each well in a 96 well plate, and absorbance was read at 405 nm in a 
microplate reader (Multiskan Spectrum, Thermo Fisher Scientific Inc.).  
 
3.3.7 Detection of mitochondrial cytochrome c release 
Mitochondrion-selective MitoTracker probes were used according to the 
manufacturer’s protocol. Cells were seeded in 12-well plates with coverslips and incubated 
in NG or HG. Cells were then incubated in MitoTracker solution for 15 minutes at 37°C. 
Cells were fixed in 4% Paraformaldehyde for 20 minutes at room temperature and 
permeabilized using 0.1% Triton X-100. Overnight incubation with Cytochrome C primary 
antibody, followed by 1 hour of anti-goat secondary antibody was performed. Coverslips 
were mounted on microscope glass slides with DAPI mounting medium (Vector 
Laboratories Inc., USA) and analyzed using fluorescence microscopy. 
 
3.3.8 Western Blot 
After treatment, H9c2 cells were washed in PBS. 120uL of lysis buffer [0.5 M tris-
hydrochloride pH 6.8, 2% (vol/vol) SDS, 15% (vol/vol) glycerol, 10% (vol/vol) 2-
mercaptoethanol and protease inhibitor cocktail] was added to each well and cells were 
scraped off. The lysates were then incubated at 95C for 10 minutes. Approximately 35ug of 
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protein was loaded to each well. Samples were analyzed by SDS-PAGE and transferred to 
a PVDF membrane. After blocking 1 hour in 3% BSA, specific primary antibodies, LC3B 
and b-actin (1:1000, Cell Signaling, MA), were used. Then, HRP-linked anti-rabbit (1:5000, 
Cell Signaling, MA) was used as secondary antibody, and proteins were detected using 
enhanced chemiluminescence reagents. Band intensity was quantified using ImageJ 
software. 
 
3.3.9 Statistical analysis 
All data are presented as mean ± SEM. Statistical analysis was performed using 
Student’s t-test. Differences between groups were considered statistically significant when 
p<0.05 and are indicated by symbols as described in figure legends.  
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3.4 Results 
 
3.4.1 High glucose-induced apoptosis and adiponectin alleviation of high glucose-
induced apoptosis in H9c2 cells 
In order to determine H9c2 cell viability upon high glucose treatment, a series of 
different assays were used. Cells were treated with either normal glucose (NG; 5.5mM) or 
high glucose (HG; 25mM) for 24, 48, and 72 hours, and co-treated with adiponectin. The 
concentration of adiponectin used was based on our preliminary data, as well as those 
used in a previous publication [86]. First, cells were incubated with either NG or HG media 
for 72 hours, and it was found that there was significant increase in trypan blue-stained 
cells in the HG-treated condition (Figure 3.1-A). We confirmed this finding in another 
apoptosis assay by using Annexin V/PI staining. In early apoptosis, phosphatidylserine (PS) 
is externalized to the outer membrane of the phospholipid bilayer. Cells started to expose 
PS to the external membrane after 24 hours of incubation with HG media, as was shown 
by FITC-annexin V binding (Figure3.1-B). Cells were counterstained with propidium 
iodide(PI) to distinguish between apoptosis and necrosis. The viability of H9c2 cells was 
also confirmed by TUNEL assay, where there were more TUNEL-stained cells observed 
under HG conditions (Figure 3.1-C). Finally, we assessed activation of caspase-3 in order 
to elucidate the form of cell death induce by hyperglycemia. A significant increase in 
caspase-3 activity was detected upon 48 hours of treatment with HG media (Figure 3.1-D). 
These results showed that treatment with adiponectin significantly abrogated the effects of 
hyperglycemia on H9c2 cell viability. 
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Figure 3.1: Adiponectin treatment attenuated high glucose-induced apoptosis in 
H9c2 cells H9c2 cells were grown in 10% FBS, then treated with either NG or HG in 0.5% 
FBS with or without fAd (5.0ug/mL) when 80% confluence reached. Then (A) Cell viability 
was assessed by trypan blue exclusion assay for 72 hr treatment. Number of dead cells for 
HG are normalized to NG incubation. (B) Annexin V binding assay shows PS exposure to 
the outer membrane. Annexin V is shown in green and PI is shown in red fluorescence. (C) 
TUNEL assay with DAPI were performed for DNA fragmentation analysis (D)Activity of 
caspase-3 were performed using colorimetric assay. (n=>3) * indicates p<0.05 vs NG. 
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3.4.2 High glucose- induced H9c2 cells undergo apoptosis through the intrinsic 
pathway 
Cytochrome C is considered to be a pro-apoptotic marker when found outside of 
mitochondria. To examine whether HG induced the intrinsic pathway of the apoptosis, co-
localization of cytochrome C and mitochondria was performed. As seen in merged images, 
brighter yellow appeared in NG conditions compared to dominant orange to red in HG 
(Figure 3.2-A). The results were quantified by Pearson’s coefficient and there was a 
significant decrease in the HG condition, which means there was less co-localization 
(Figure 3.2-B). These results suggest that apoptosis is activated through intrinsic pathway 
upon hyperglycemia in H9c2 cells.  
 
Figure 3.2: High glucose inducing intrinsic apoptotic pathway H9c2 cells were grown 
in 10% FBS, then treated with either NG or HG when 80% confluence reached. 
Representative images to show single slice image for DAPI (Blue), mitotracker (Red), 
Cytochrome C (Green), and Merged. In NG there are more co-localization of cytochrome 
C with mitochondria represented by dominant yellow puncta compared to HG with 
dominant orange to red signals. Images were analyzed using Pearson’s coefficient for their 
co-localization (B). * indicates significant difference from NG (n=3) p<0.05. 
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3.4.3 High glucose blocked autophagy, but adiponectin restored autophagy 
Autophagy was examined using Western blotting to look at the expression level of 
proteins that are involved in autophagy flux. The level of the lipidated form of LC3, LC3II, is 
a hallmark of autophagosome formation. In HG conditions, the level of LC3II increased 
compared to the NG condition. This level was then reduced when adiponectin was 
supplemented (Figure 3.3 A,B).  
 
Figure 3.3: High glucose disturbing autophagy flux H9c2 cells were grown in 10% FBS, 
then treated with either NG or HG with or without fAd (5ug/mL) when 80% confluence 
reached. Western blot showing LC3B and loading control GAPDH (A) and its quantification 
for lipidated form of LC3B, LC3II over GAPDH (B). (n=3) No significant difference 
observed. 
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Figure 3.4: Adiponectin reduced HG-induced apoptosis even in autophagy deficient 
cells. Atg5K130R and EV- H9c2 cells were grown in 10% FBS, then treated with either NG 
or HG when 80% confluence reached. Representative images to show increased 
activation of caspase-3 (Green) in HG condition, using CellEvent Caspase-3/7 
immunofluoresence (A). Atg5K130R and EV- H9c2 cells were grown in 10% FBS, then 
treated with either NG or HG with or without fAd (5ug/mL). Western blot showing caspase-
3 and loading control beta actin (B) and its quantification for cleaved caspase-3 over beta-
actin (C) (n=1). 
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3.4.4 Adiponectin reduced HG-induced apoptosis even in autophagy deficient cells 
To investigate the role of autophagy in cardiomyocyte cell death, autophagy deficient 
H9c2 cells were generated. Cells were transduced with a retrovirus to stably overexpress 
a mutant Atg5 gene. Empty vector (EV) was used as control for the experiment. Caspase-
3/7 activity assay using immunofluorescence showed that there was an increased level of 
activation in Atg5K130R cells compared to EV. In the response HG, there was a further 
increase in activity. To study the mechanism behind the effect of adiponectin activating 
autophagy to reduce apoptosis, I compared caspase-3 levels by western blot. After 24 
hour HG treatment there was an increased level of capsase-3 activity observed in EV but 
not in Atg5K130R cells. In response to adiponectin, HG-induced caspase-3 activation was 
reduced in both cell types.  
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3.5 Discussion  
Hyperglycemia is a key feature in diabetic patients and animals. This can be 
problematic, as it is known that hyperglycemic conditions cause cell death in 
cardiomyocytes, as well as other cell types. However, this cell death could potentially be 
prevented by a hormone that is secreted by adipocytes, adiponectin [58]. In this project, I 
confirmed that HG conditions trigger cell death in H9c2 cells, but this was attenuated with 
adiponectin co-treatment. My overall goal was to determine the mechanism behind this 
phenomenon, and so far, I have found that this occurs through the induction of autophagy.  
My experiments showed that adiponectin could significantly reduce hyperglycemia-
induced cell death in cardiomyocytes. First of all, H9c2 cells responded to HG conditions 
with increased cell death. Specifically, it induced the intrinsic pathway of apoptosis. 
Consistent with my data, previous research in mesangial cells as shown that HG induced 
the intrinsic pathway of apoptosis by stimulating cytochrome c release from mitochondria 
[87]. A large number of mitochondria can be found in cardiomyocytes [29]. This might be 
the reason why HG-stimulated damage to mitochondria leads to activation of the intrinsic 
pathway of apoptosis. However, this HG-induced apoptosis was attenuated when cells 
were co-treated with adiponectin. Adiponectin is known to have cardioprotective effects 
against ischemia-reperfusion injury [88], atherosclerosis, and inflammation [63]. However, 
it was not directly proven that adiponectin has a beneficial effect under hyperglycemic 
conditions. My research shows that adiponectin significantly reduced cell death in 
cardiomyocytes exposed to chronic HG conditions.  
One of the possible mechanisms underlying this phenomenon is autophagy. I found 
that it was impaired by HG treatment, but restored upon co-treatment with adiponectin. 
Autophagy is a very important mechanism to maintain cardiac homeostasis. Adiponectin is 
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known to stimulate AMPK, a critical protein for the maintenance of cellular homeostasis 
known to be involved in the initiation of autophagy. I hypothesized that there might be link 
between autophagy and adiponectin function in the prevention of apoptosis. Even though I 
did not find direct activation of AMPK by adiponectin in H9c2 cells, I found that autophagy 
was restored by adiponectin treatment under HG conditions.  
To investigate the link between autophagy and apoptosis, an autophagy-deficient 
cardiomyocyte cell line, Atg5K130R, was used. There was an increase in casapse-3 activity 
in Atg5K130R cells at baseline, and especially more death was observed when cells were 
exposed to HG. This was confirmed by an increased number of punctae in Atg5K130R cells 
using caspase-3/7 activity immunofluorescence. It has been previously shown that if 
autophagy is impaired, it could lead to cardiomyopathy [29]. However, strikingly, even in 
autophagy-deficient cells, adiponectin reduced hyperglycemia-induced caspase-3 
activation. This suggests that adiponectin may function through a different pathway when 
autophagy is not fully functioning. 
In conclusion, apoptosis induced by hyperglycemic conditions in H9c2 cells was 
attenuated with adiponectin treatment. However, further studies on the effect of 
adiponectin and autophagy on reducing apoptosis are definitely warranted.  
For future studies, more autophagy markers need to be studied such as pAMPK, 
pULK1, and p62. In order investigate initiation of the autophagy pathway, it is important to 
determine the related status of phosphorylated AMPK and mTOR activity.  
Modulating autophagy can be a therapeutic target for CVDs. Through my research, I 
propose that adiponectin is one of the key hormones that can mediate this pathway.   
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Chapter Four: General Conclusion and Future Direction 
4.1 Summary 
Metabolic syndrome is a group of risk factors that collectively contribute to increased 
risk of serious diseases such as CVD. High glucose and high lipid levels in the blood, and 
high blood pressure are some of examples of risk factors that fall into this category. 
Additionally, studies now show that iron overload can also be a new factor to predict the 
development of CVD and diabetes. Generally, the level of iron storage in the body is 
correlated with development of T2D [40]. And patients with T2D have limitation in glucose 
metabolism in heart and skeletal muscle [89]. Previously it was focused on oxidative stress 
in skeletal muscle and cardiac muscle because those play important role carrying and 
utilizing oxygen for glucose metabolism especially during exercise. Both in skeletal muscle 
and cardiac muscle, there are high demand for mitochondria due to metabolic demand for 
their function [90].  
During my master’s study, using two different types of muscle cells, I investigated the 
mechanisms involved in metabolic syndrome-induced cell death. There are three types of 
specialized myocytes- cardiac, skeletal, and smooth muscle cells. Among them, 
cardiomyocytes and skeletal muscle cells have in common that they are both striated cells. 
This striation is important for cells to have independent, but harmonized function where 
some cells contract, and the others relax.  
My study proved that upon the stimuli, iron overload and high glucose, the apoptosis 
activation increased with mitochondria-dependent pathway. Mitochondria are important in 
terms of maintaining homeostasis in cellular level such as ROS signaling, intrinsic pathway 
of apoptosis regulation, and energy production [91]. Especially, the importance of 
mitochondria in oxidative phosphorylation and ATP production is widely acknowledged. 
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They utilize fatty acid or glucose as energy source. However, under detrimental stimuli, 
such as excessive generation of ROS, they can be damaged and cause mitochondrial 
dysfunction [92]. In my first project, I observed that prolonged iron overload conditions 
induced cell death mediated by the intrinsic apoptosis pathway in skeletal muscle cells. In 
this model, disturbed mitochondrial membrane potential resulted in release of cytochrome 
C into the cytosol, acting as pro-apoptotic molecule. Similarly, in cardiac and neuronal cells, 
iron overload-induced apoptosis has been shown to be mediated through a mitochondria- 
caspase-3 dependent pathway as well [50]. Therefore, iron overload can definitely trigger 
the intrinsic pathway of apoptosis not only in skeletal muscle cells, but many different cell 
types. In my second project, I also added on potential therapeutic target, adiponectin, on 
HG- induced cell death in cardiac muscle cells. Adiponectin is an adipokine that has been 
shown to have beneficial roles in many cardiac remodelling events such as inflammation, 
atherosclerosis, and diabetes [58]. I determined that exposure to prolonged HG conditions 
resulted in increased cell death at different time points, and adiponectin significantly 
reduced this event. I also demonstrated that this activation of cell death was possibly 
through the intrinsic pathway of apoptosis by showing reduced co-localization of 
cytochrome C and mitochondria.  
Sarcopenia and heart failure are common outcome of decline in quality of skeletal 
muscle cells and cardiac muscle cells, respectively. Sarcopenia is a condition of reduced 
muscle mass [21] and heart failure is a condition of loss of contractility [93]. In skeletal 
muscle, this muscle dysfunction will be resulted by reduced oxidative phosphorylation [94]. 
Malfunctioning heart will have reduced oxidative phosphorylation, as well as decreased 
number of mitochondria and their enzyme [95, 96]. Further these losses of cellular function 
are closely related to aging. Aging can be defined many different ways. In terms of cells, it 
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can be defined as changes in metabolism [92] or imbalance in homeostasis. 
Because autophagy is now a well-known cell survival mechanism, I proposed that 
iron overload and high glucose could disrupt normal autophagy to cause cell death. 
Especially in skeletal and cardiac myocytes, autophagy is the crucial process to prevent 
cells from accumulating damaged or dysfunctional proteins and organelles [97]. Having 
impaired autophagy in muscle and heart can cause sarcopenia and cardiomyopathy [98]. 
In the context of autophagy, I observed that significant autophagosome induction. Increase 
in autophagosomes can be reflective of either an increase in autophagy or reduction of 
autophagosomal degradation; however, I witnessed that many have found increased 
autophagosome level was indication of blockage of autophagic flux [99, 100]. This is one 
of limitation to my study, that in both projects, autophagic degradation was not measured. 
One might argue no definite conclusion can be made at this point, so this can be 
elucidated by further study. Benefit to learn autophagy in skeletal muscle and cardiac 
muscle is that it can be applied to exercise training, potentially change lifestyle to 
overcome metabolic syndrome. [101].  
Lastly, in order to examine other possible pathways that cause cell death in skeletal 
muscle cells with iron overload oxidative stress was studied. Previously researchers have 
found that production of ROS through the Fenton reaction was mediated by iron, and 
levels of ROS were elevated in iron-overload patients. Overproduction of ROS causing 
apoptosis is extensively studied, especially in relation to damage to mitochondria. Also, 
cells can induce autophagy to remove damaged proteins and organelles to protect the cell 
against oxidative stress. However, crosstalk between autophagy and oxidative stress to 
induce apoptosis in iron overload conditions is not yet well studied. Therefore, I propose 
that future studies should investigate their relationship and mechanism(s) to induce cell 
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death.   
 
4.2 Future direction  
Further studies can be conducted in order to have better understanding of the 
mechanisms responsible for myocyte apoptosis in metabolic syndrome. For future studies, 
the relationship between oxidative stress and iron overload-induced cell death can be 
studied. Previous literature has shown that co-treating with iron and the antioxidant 
reagent N-Acetyl-Cysteine (NAC) for 120 hours prevented cell death in osteoblasts [102]. 
My expectation is that a similar phenomenon will be observed in skeletal muscle cells, 
where preventing oxidative stress results in the prevention of cell death. Then, crosstalk 
between autophagy and oxidative stress to trigger apoptosis by iron overload can be 
investigated. The effect of iron overload on oxidative stress when autophagy is deficient 
can be studied using the same cell line, Atg5K130R.  
In terms of studying the effect of adiponectin on alleviating cell death via controlling 
the autophagic pathway, detailed analysis of the autophagic pathway can be performed. 
There are many steps in autophagy that can be regulated. Some studies have shown that 
adiponectin regulates in initiation step when AMPK phosphorylation occurs [103]. Other 
studies have pointed out that beclin-1 is important protein to regulate crosstalk between 
apoptosis and autophagy [67]. Additionally, other pathways that adipoenctin can activate to 
reduce apoptosis can also be investigated.  
Also, In vivo experiments can be done for future studies to complement in vitro 
studies. In my lab, we have designed autophagy knockout model mice, which is specific to 
heart. Further study can be conducted using heart sample from that model, to look at the 
apoptotic activity when the adiponectin is supplemented. With inducing iron overload in 
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this specific mice model, skeletal muscle samples can be obtained to measure apoptotic 
activity. And further study to learn mitochondria specific characteristic such as 
mitochondria biogenesis and mitophagy since as mentioned previously, mitochondria play 
important role in metabolic syndrome induced cell death.  
Taken together, results from my in vitro studies and previously published data 
suggest the importance of autophagy in regulating apoptosis. Therefore, this provides 
potential therapeutic target to reduce apoptosis and protect different types of muscles in 
optimal condition. Iron overload and hyperglycemic condition induced mitochondria-
dependent intrinsic apoptotic pathway and reduced autophagy in skeletal muscle cells and 
cardiomyocytes respectively. Meanwhile, co-treatment of adiponectin in hyperglycemia 
condition altered this event by inhibiting apoptosis. It is not clear which is the cause or 
effect, as there is a correlation between iron metabolism and glucose metabolism. Iron can 
modulate glucose metabolism and glucose metabolism can impact the iron pathway [40]. 
For this reason, thorough investigation of how to stimulate or inhibit underlying 
mechanisms as therapeutic target to reduce disease associated with myocyte apoptosis, 
sarcopenia and heart failure in metabolic syndrome would be appreciated.  
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